Page last updated: 2024-10-30

mefenamic acid and Cerebral Infarction

mefenamic acid has been researched along with Cerebral Infarction in 1 studies

Mefenamic Acid: A non-steroidal anti-inflammatory agent with analgesic, anti-inflammatory, and antipyretic properties. It is an inhibitor of cyclooxygenase.
mefenamic acid : An aminobenzoic acid that is anthranilic acid in which one of the hydrogens attached to the nitrogen is replaced by a 2,3-dimethylphenyl group. Although classed as a non-steroidal anti-inflammatory drug, its anti-inflammatory properties are considered to be minor. It is used to relieve mild to moderate pain, including headaches, dental pain, osteoarthritis and rheumatoid arthritis.

Cerebral Infarction: The formation of an area of NECROSIS in the CEREBRUM caused by an insufficiency of arterial or venous blood flow. Infarcts of the cerebrum are generally classified by hemisphere (i.e., left vs. right), lobe (e.g., frontal lobe infarction), arterial distribution (e.g., INFARCTION, ANTERIOR CEREBRAL ARTERY), and etiology (e.g., embolic infarction).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kelly, JJ1
Auer, RN1

Other Studies

1 other study available for mefenamic acid and Cerebral Infarction

ArticleYear
Mefenamate, an agent that fails to attenuate experimental cerebral infarction.
    The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, 2003, Volume: 30, Issue:3

    Topics: Animals; Atrophy; Brain; Cations; Cerebral Infarction; Ion Channels; Male; Mefenamic Acid; Necrosis;

2003